FLT3 and acute promyelocytic leukemia: 37% of the relapsing patients exhibited FLT3-ITD mutations which were positively associated with PRα/LBD mutations in APL patients relapsing on ATRA and negatively associated with PRα/LBD mutations in those relapsing off ATRA [87].